Diaceutics PLC

Investor Overview

At Diaceutics we believe that every patient should have access to the right treatment at the right timeWe provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®.

DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories.

Investor Factsheet

Download our latest Investor Factsheet outlining key details about the DXRX business model and the opportunities for the platform to deliver a real difference in a high growth market.

Financial Calendar

2021

Year End
31st Dec

2022

Half Year End
30th Jun
Release of Final Results FY21
22nd Mar
Group FY21 Results investor webinar
23rd Mar

Have a question?

Why invest in Diaceutics?

Diaceutics PLC H1 2022 Results presentation Slide Deck

Corporate Governance

Financial Calendar

2021

Year End
31st Dec

2022

Half Year End
30th Jun
Release of Final Results FY21
22nd Mar
Group FY21 Results investor webinar
23rd Mar

Why invest in Diaceutics?

Diaceutics PLC H1 2022 Results presentation Slide Deck

Have a question?

Corporate Governance

Investor Alerts

If you would like to recieve investor email alerts, simply complete this form. If you have already subscribed, you can change your settings or unsubscribe here.